Funding: Christine Lu was supported by an Australian National Health and Medical Research Council postgraduate scholarship (grant number 351040).
Has the use of disease-modifying anti-rheumatic drugs changed as a consequence of controlled access to high-cost biological agents through the Pharmaceutical Benefits Scheme?
Article first published online: 2 JUN 2007
2007 Royal Australasian College of Physicians
Internal Medicine Journal
Volume 37, Issue 9, pages 601–606, September 2007
How to Cite
Lu, C. Y., Williams, K. M. and Day, R. O. (2007), Has the use of disease-modifying anti-rheumatic drugs changed as a consequence of controlled access to high-cost biological agents through the Pharmaceutical Benefits Scheme?. Internal Medicine Journal, 37: 601–606. doi: 10.1111/j.1445-5994.2007.01396.x
Potential conflicts of interest: A/Professor Ken Williams has been a member of the Advisory Board to the sponsor for adalimumab. Professor Ric Day is a member of the Advisory Board to sponsors for adalimumab, infliximab and anakinra in Australia. A/Professor Williams and Professor Day have also been contracted to undertake clinical trials of etanercept, infliximab, adalimumab and anakinra. Recompense for these activities is placed in audited hospital trust funds for use in the research activities of the Clinical Pharmacology Department, St Vincent’s Hospital, Sydney.
- Issue published online: 2 JUN 2007
- Article first published online: 2 JUN 2007
- Received 3 August 2006; accepted 19 March 2007.
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.